WO2001062260A3 - Amelioration d'un taux d'implantation - Google Patents

Amelioration d'un taux d'implantation Download PDF

Info

Publication number
WO2001062260A3
WO2001062260A3 PCT/EP2001/001691 EP0101691W WO0162260A3 WO 2001062260 A3 WO2001062260 A3 WO 2001062260A3 EP 0101691 W EP0101691 W EP 0101691W WO 0162260 A3 WO0162260 A3 WO 0162260A3
Authority
WO
WIPO (PCT)
Prior art keywords
improvement
implantation rate
implantation
rate
preimplantational
Prior art date
Application number
PCT/EP2001/001691
Other languages
English (en)
Other versions
WO2001062260A2 (fr
Inventor
Christa Hegele-Hartung
Peter Esperling
Thorsten Blume
Original Assignee
Schering Ag
Novo Nordisk As
Hegele Hartung Christa
Peter Esperling
Thorsten Blume
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag, Novo Nordisk As, Hegele Hartung Christa, Peter Esperling, Thorsten Blume filed Critical Schering Ag
Priority to AU33765/01A priority Critical patent/AU3376501A/en
Publication of WO2001062260A2 publication Critical patent/WO2001062260A2/fr
Publication of WO2001062260A3 publication Critical patent/WO2001062260A3/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Reproductive Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Organic Chemistry (AREA)
  • Pregnancy & Childbirth (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

La présente invention concerne l'utilisation de FF-MAS et/ou de ses analogues pour la préparation d'un médicament pouvant augmenter le taux d'implantation d'embryons préimplantatoires.
PCT/EP2001/001691 2000-02-25 2001-02-15 Amelioration d'un taux d'implantation WO2001062260A2 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU33765/01A AU3376501A (en) 2000-02-25 2001-02-15 Improvement of implantation rate

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP00250067.6 2000-02-25
EP00250067 2000-02-25

Publications (2)

Publication Number Publication Date
WO2001062260A2 WO2001062260A2 (fr) 2001-08-30
WO2001062260A3 true WO2001062260A3 (fr) 2002-04-04

Family

ID=8172594

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2001/001691 WO2001062260A2 (fr) 2000-02-25 2001-02-15 Amelioration d'un taux d'implantation

Country Status (2)

Country Link
AU (1) AU3376501A (fr)
WO (1) WO2001062260A2 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2001240624A1 (en) * 2000-02-25 2001-09-03 Novo-Nordisk A/S Improvement of implantation rate
EP1245572A1 (fr) 2001-03-26 2002-10-02 Schering Aktiengesellschaft Composés aminostérols, leur utilisation pour la préparation des médicaments pour la régulation de la méiose et un procédé de leur préparation

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5716777A (en) * 1994-06-23 1998-02-10 Novo Nordisk A/S Regulation of meiosis using sterols
WO1998055498A1 (fr) * 1997-06-04 1998-12-10 Akzo Nobel N.V. DERIVES DE 17β-ALLYLOXY(THIO)ALKYL-ANDROSTANE DESTINES A UNE MODULATION DE MEIOSE
WO1999061010A2 (fr) * 1998-05-26 1999-12-02 Schering Aktiengesellschaft TRAITEMENT DE L'INFERTILITE PAR DES COMPOSES STIMULANT LA PRODUCTION D'AMPc, SEULS OU ASSOCIES A AU MOINS UN COMPOSE STIMULANT LA MEIOSE
WO2000050065A1 (fr) * 1999-02-24 2000-08-31 Novo Nordisk A/S Traitement de l'infecondite
WO2000050066A1 (fr) * 1999-02-24 2000-08-31 Novo Nordisk A/S Traitement de l'infecondite
WO2000052142A2 (fr) * 1999-02-26 2000-09-08 Novo Nordisk A/S Sterol activant la meiose et augmentant le taux d'implantations

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5716777A (en) * 1994-06-23 1998-02-10 Novo Nordisk A/S Regulation of meiosis using sterols
WO1998055498A1 (fr) * 1997-06-04 1998-12-10 Akzo Nobel N.V. DERIVES DE 17β-ALLYLOXY(THIO)ALKYL-ANDROSTANE DESTINES A UNE MODULATION DE MEIOSE
WO1999061010A2 (fr) * 1998-05-26 1999-12-02 Schering Aktiengesellschaft TRAITEMENT DE L'INFERTILITE PAR DES COMPOSES STIMULANT LA PRODUCTION D'AMPc, SEULS OU ASSOCIES A AU MOINS UN COMPOSE STIMULANT LA MEIOSE
WO2000050065A1 (fr) * 1999-02-24 2000-08-31 Novo Nordisk A/S Traitement de l'infecondite
WO2000050066A1 (fr) * 1999-02-24 2000-08-31 Novo Nordisk A/S Traitement de l'infecondite
WO2000052142A2 (fr) * 1999-02-26 2000-09-08 Novo Nordisk A/S Sterol activant la meiose et augmentant le taux d'implantations

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
BYSKOV A G ET AL: "CHEMICAL STRUCTURE OF STEROLS THAT ACTIVATE OOCYTE MELOSIS", NATURE, MACMILLAN JOURNALS LTD. LONDON, GB, vol. 374, no. 6, 6 April 1995 (1995-04-06), pages 559 - 562, XP002901116, ISSN: 0028-0836 *
SMITZ J ET AL: "OOCYTE IN-VITRO MATURATION AND FOLLICLE CULTURE: CURRENT CLINICAL ACHIEVEMENTS AND FUTURE DIRECTIONS", HUMAN REPRODUCTION, IRL PRESS, OXFORD, GB, vol. 14, no. SUPPL 1, 1999, pages 145 - 161, XP002901118, ISSN: 0268-1161 *

Also Published As

Publication number Publication date
WO2001062260A2 (fr) 2001-08-30
AU3376501A (en) 2001-09-03

Similar Documents

Publication Publication Date Title
PL352554A1 (en) Sulfonamide or sulfamide substituted amidazoquinolines
WO2002046189A3 (fr) Imidazoquinolines substituees aryl ether
IL196301A0 (en) Medicament for the treatment of hapatitis c
AU2001277543A1 (en) Synergistically active mixture which inhibits hair growth
AU2000279625A1 (en) Blood mmp-3 level-lowering agent containing il-6 antgonist as the active ingredient
WO2001078683A3 (fr) Formulations a liberation lente
AU2001266075A1 (en) Combinations of active ingredients, which exhibit insecticidal and acaricidal properties
AU6607501A (en) Combinations of active ingredients, which exhibit insecticidal and acaricidal properties
GB0100658D0 (en) Crystallisation - resistant aqueous growth hormone formulations
AU2061702A (en) Combination of catechin and quercetin for pharmaceutical or dietary use
WO2002015959A3 (fr) Composes et compositions permettant de distribuer des agents actifs
HK1068106A1 (en) Use of sarp-1 for the treatment and/or prevention of scleroderma
MXPA03003741A (es) Metodos y composiciones para el tratamiento de enfermedades oftalmicas.
AU2001266945A1 (en) Synergistic biocidal compositions
WO2002060972A3 (fr) Polyalkoxyalkylsiloxanes anti-neoplasiques et procedes d'utilisation
AU2001278680A1 (en) Erectile dysfunction remedies containing prostaglandin derivatives as the activeingredient
AU2001284125A1 (en) Medicine for fighting against sexual dysfunction
WO2001062260A3 (fr) Amelioration d'un taux d'implantation
WO2002024181A3 (fr) Utilisation de la melatonine pour induire une anesthesie generale
EP1273301A3 (fr) Préparations pharmaceutiques comprenant des principes actifs susceptibles d'administration illicite
ZA200110533B (en) Aqueous concentrate pesticidal compositions having improved dermal and ocular safety.
AU2002364283A1 (en) Prenyltransferase from plants
ZA200210361B (en) Method of administering bishosphonates.
WO2001062258A3 (fr) Amelioration du taux d'implantation
WO2002036105A3 (fr) Utilisation d'agents sequestrants de cortisol dans le cadre du traitement de troubles lies a l'hypercortisolemie

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
AK Designated states

Kind code of ref document: A3

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

NENP Non-entry into the national phase

Ref country code: JP